Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Common Equity (2016 - 2025)

Hypha Labs filings provide 15 years of Common Equity readings, the most recent being -$2.4 million for Q3 2025.

  • On a quarterly basis, Common Equity fell 93.35% to -$2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.4 million, a 93.35% decrease, with the full-year FY2025 number at -$2.4 million, down 93.35% from a year prior.
  • Common Equity hit -$2.4 million in Q3 2025 for Hypha Labs, down from -$2.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$471661.0 in Q1 2024 to a low of -$2.9 million in Q1 2023.
  • Median Common Equity over the past 5 years was -$1.8 million (2025), compared with a mean of -$1.8 million.
  • Biggest five-year swings in Common Equity: tumbled 685.76% in 2021 and later soared 83.78% in 2024.
  • Hypha Labs' Common Equity stood at -$1.5 million in 2021, then crashed by 89.17% to -$2.9 million in 2022, then grew by 28.76% to -$2.1 million in 2023, then increased by 23.77% to -$1.6 million in 2024, then crashed by 55.76% to -$2.4 million in 2025.
  • The last three reported values for Common Equity were -$2.4 million (Q3 2025), -$2.1 million (Q2 2025), and -$1.8 million (Q1 2025) per Business Quant data.